July 26, 2014 1:52 PM ET

Biotechnology

Company Overview of TransMolecular, Inc.

Company Overview

As of March 2011, TransMolecular, Inc. was acquired by Morphotek, Inc. TransMolecular, Inc. engages in discovering, developing, and commercializing therapies for glioma, metastatic brain tumors, and cancers. It offers TM601, a synthetic a polypeptide based on amino acid peptide derived from scorpion venom, which is used to treat cancer. The company was founded in 1996 and is based in Cambridge, Massachusetts.

840 Memorial Drive

Second Floor

Cambridge, MA 02139

United States

Founded in 1996

Phone:

617-995-3050

Fax:

617-995-3049

Key Executives for TransMolecular, Inc.

TransMolecular, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Hygeia Therapeutics, Inc. United States
Satori Pharmaceuticals Incorporated United States
Stowers Institute For Medical Research Inc. United States
Origen, Inc. United States
Oricula Therapeutics LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TransMolecular, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.